Send us Feedback

Walgreen Company (WAG)
Analysis
SUMMARY
BULLS
BEARS
TOPICS
Data
DATA CENTRAL
STOCK CHART
Financials
SEC FILINGS
BALANCE
INCOME
CASH FLOW

 
Annual Reports

 
Quarterly Reports

 
8-K

  • 8-K (May 15, 2013)
  • 8-K (May 7, 2013)
  • 8-K (Mar 20, 2013)
  • 8-K (Mar 19, 2013)
  • 8-K (Mar 6, 2013)
  • 8-K (Feb 8, 2013)

 
Other

Walgreen Company 8-K 2010

Documents found in this filing:

  1. 8-K/A
  2. Graphic
  3. Graphic
walgreen_8k.htm

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K/A

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): February 23, 2010

 
Walgreen Co. Logo

 
WALGREEN CO.
(Exact name of registrant as specified in its charter)

Illinois
  
1-604
  
36-1924025
(State or other jurisdiction of incorporation)
  
(Commission File Number)
  
(IRS Employer Identification No.)

200 Wilmot Road, Deerfield, Illinois
  
60015
(Address of principal executive offices)
  
(Zip Code)

Registrant’s telephone number, including area code:(847) 940-2500

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))


 
 
 
 
    This amendment to the current report on Form 8-K/A filed by Walgreen Co. on March 24, 2010 (the “Original Report”) is being filed to clarify the scope of Stanley B. Blaylock’s non-competition restrictions.
 
Item 5.02
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 
    On February 23, 2010, Stanley B. Blaylock, senior vice president of Walgreen Co. (the “Company”) and president of Walgreens Health Services, informed the Company that he will leave the Company in April after a transition period.  Subsequently, the parties agreed on April 2, 2010 as the effective date of Mr. Blaylock’s separation from the Company (“Separation Date”).
 
    Mr. Blaylock and the Company have entered into a Separation and Release Agreement to confirm the terms and conditions of Mr. Blaylock’s separation from the Company.  The material terms and conditions of the Agreement are as follows:

·  
Mr. Blaylock will receive severance of $900,000, which represents 18 months of base salary, and continuing health benefits during the same 18-month period, commencing immediately after the Separation Date.  The severance will be paid to Mr. Blaylock in 18 monthly installments, in accordance with the Company’s normal payroll process and subject to all applicable withholdings and deductions.

·  
Mr. Blaylock will be eligible to receive a pro-rated bonus on account of the portion of fiscal year 2010 ending on June 23, 2010, which represents the Separation Date plus the remaining unused vacation days that are due to Mr. Blaylock.  The bonus will be calculated in the same manner as it is calculated for other comparable senior executives who remain employed by the Company and paid only to the extent bonuses are paid to a majority of the Company’s executives.

·  
Mr. Blaylock also will be entitled to pro-rated vesting through June 23, 2010 of: restricted stock and restricted stock units granted under the Long-Term Performance Incentive Plan; and restricted cash and stock granted under the former Restricted Performance Share Program.  All other unvested long-term incentives will be forfeited as of June 23, 2010, and all vested stock options will expire as of that same date.

·  
Mr. Blaylock has agreed to non-competition restrictions and non-solicitation restrictions for a period of 18 months following the Separation Date.  For the 12 month period thereafter, he has agreed to not consult with, accept employment with or provide services on behalf of three named competitor companies.

SIGNATURE
 
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
WALGREEN CO.
  
       
Date: March 25, 2010
By:
/s/ Dana I. Green
  
   
Name: Dana I. Green
  
   
Title: Executive Vice President, General Counsel
and Secretary
 
 
       
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki